Regional News • Asia • India

Russian Covid-19 vaccine Sputnik V to be produced by India Indian drugmaker

The Russian sovereign wealth fund (RDIF) has concluded another agreement for the production of the Corona vaccine Sputnik V in India. The agreement with the company Stelis from the Indian pharmaceutical group Strides provides for the production of at least 200 million doses of the vaccine from the third quarter of 2021, as the sovereign wealth fund announced on Friday. In November, RDIF had already signed an agreement with Indian group Hetero for 100 million doses annually.

In contrast to dozens of other countries, the Russian vaccine has not yet been approved in India, where clinical trials are still underway. At the same time, Moscow is counting on broadening the production of the vaccine due to the high international demand in the pandemic.

co-founder of Pendect. Trying to protect free speech and democracies by creating a global news platform that is built through expert contribution. In love with vinyl, psytrance and penguins.
Card reviewed by: @ericof